Acute Mi

2

Review clinical trials related to Acute Mi. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

The primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease burden using an algorithm obtained from biomarkers and diagnostics utilizing remote sensor driven technology tools, care coordination and patient empowerment.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Aventyn, Inc.Updated: Feb 12, 2026Locations: 5
Eligibility criteria

Men and women over 18 years of age are included [+5]

Those subjects who are not willing to sign an informed consent

Status: Recruiting

Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions

Heart failure is a syndrome that is defined by distinctive clinical, hemodynamic, and neurohormonal findings. HF represents a final common pathway for many different cardiovascular diseases, including coronary disease, hypertension, Valvular disease, and many primary heart muscle diseases. Clinically, HF patients experience dyspnea, fatigue and diminished exercise tolerance, reflecting elevated left and/or right ventricular filling pressures and decreased cardiac output.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Aventyn, Inc.Updated: Mar 20, 2024Locations: 1
Eligibility criteria

Study informed consent will be obtained before enrollment in the study for Phase... [+4]